In TMZ-resistant GBM tumors, numerous molecular pathways such as nuclear factor kappa light chain enhancer of activated B cells (NF-κB), p53, and JAK-STAT are found to be commonly dysregulated [8]. This evidence concerns the gene SOAT1 and glioblastoma.